Every material Form 8-K CME filed with the SEC in 2024, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
CME Group's board approved an amended employment agreement extending Chairman and CEO Terry Duffy's term through December 31, 2026, with base salary, target bonus and long-term incentive targets unchanged. The company also named CFO Lynne Fitzpatrick President and CFO, and COO Julie Holzrichter is stepping down to become an advisor, with Suzanne Sprague succeeding her as COO. The filing reports no financial results, so the changes affect shareholders mainly through leadership continuity and the terms of executive compensation.
Duffy's employment term extended to December 31, 2026; the agreement may be extended further to December 31, 2027
Lynne Fitzpatrick promoted to President and Chief Financial Officer; she has served as CFO since April 2023
Julie Holzrichter, COO since 2014, steps down and will remain with the company as an advisor
Suzanne Sprague, Senior Managing Director and Global Head of Clearing and Post-Trade Services, assumes the COO role
CME Group reported record third-quarter 2024 revenue of $1.6 billion, up from $1.3 billion a year earlier, with net income of $913 million and diluted earnings per share of $2.50, compared with $2.06 in the third quarter of 2023. The company said the quarter was its best in history, with record average daily volume of 28.3 million contracts, and it also reported non-GAAP adjusted diluted EPS of $2.68.
Q3 2024 revenue $1.6 billion (total revenues $1,584.4 million); operating income $1,024.2 million
Diluted EPS $2.50 vs $2.06 a year earlier; adjusted diluted EPS $2.68 vs $2.25
Record quarterly ADV of 28.3 million contracts; clearing and transaction fees revenue $1.3 billion
Approximately $419 million paid in dividends during the quarter; about $2.6 billion in cash and $3.4 billion of debt as of September 30, 2024
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every CME filing is on SEC EDGAR ↗. 8-K briefs of other companies →